4H-DIBENZO(DE,G)QUINOLINE-2,10,11-TRIOL, 5,6,6A,7-TETRAHYDRO-6-PROPYL-, HYDROBROMIDE (1:1), (6AS)-
UNII Y9LP5C2RPG
Substance Identification & Data
This profile provides standardized clinical and technical data for 4h-dibenzo(de,g)quinoline-2,10,11-triol, 5,6,6a,7-tetrahydro-6-propyl-, Hydrobromide (1:1), (6as)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y9LP5C2RPG.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1217446-50-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C19H21NO3.BrH KIAIFHTWTMKEDI-RSAXXLAASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4h-dibenzo(de,g)quinoline-2,10,11-triol, 5,6,6a,7-tetrahydro-6-propyl-, Hydrobromide (1:1), (6as)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.